The hyaluronan receptor CD44 drives COVID-19 severity through its regulation of neutrophil migration
Duncan J. Hart, Md. Jashim Uddin, Rebecca J. Dodd…·William A. Petri
This study shows that blocking CD44, a hyaluronan receptor, reduces inflammation and improves survival in mice infected with SARS-CoV-2.